The Beauty Health Company (NASDAQ:SKIN) Receives Consensus Rating of “Hold” from Brokerages

The Beauty Health Company (NASDAQ:SKIN) has received an average recommendation of “Hold” from the eight ratings firms that are presently covering the firm, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have assigned a hold recommendation, one has assigned a buy recommendation and one has given a strong buy recommendation to the company. The average 12-month target price among brokers that have updated their coverage on the stock in the last year is $2.02.

Several research analysts have recently issued reports on SKIN shares. Weiss Ratings upgraded shares of Beauty Health from a “sell (e+)” rating to a “sell (d-)” rating in a report on Wednesday, July 8th. Canaccord Genuity Group lowered their price target on shares of Beauty Health from $1.50 to $1.00 and set a “hold” rating for the company in a report on Friday, May 1st. Roth Capital reissued a “buy” rating and set a $2.00 price target (down from $2.50) on shares of Beauty Health in a research report on Wednesday, May 20th. Finally, Zacks Research raised shares of Beauty Health from a “hold” rating to a “strong-buy” rating in a research report on Monday, July 13th.

Hedge Funds Weigh In On Beauty Health

Several hedge funds and other institutional investors have recently modified their holdings of SKIN. AQR Capital Management LLC bought a new stake in shares of Beauty Health in the first quarter worth about $40,000. Goldman Sachs Group Inc. increased its holdings in Beauty Health by 5.0% during the 1st quarter. Goldman Sachs Group Inc. now owns 665,706 shares of the company’s stock valued at $892,000 after purchasing an additional 31,880 shares during the period. Geode Capital Management LLC lifted its holdings in Beauty Health by 27.5% in the 2nd quarter. Geode Capital Management LLC now owns 2,302,784 shares of the company’s stock worth $4,399,000 after buying an additional 496,963 shares during the period. JPMorgan Chase & Co. lifted its holdings in Beauty Health by 54.1% in the 2nd quarter. JPMorgan Chase & Co. now owns 54,226 shares of the company’s stock worth $104,000 after buying an additional 19,032 shares during the period. Finally, Rhumbline Advisers grew its position in shares of Beauty Health by 28.6% in the 2nd quarter. Rhumbline Advisers now owns 141,982 shares of the company’s stock worth $271,000 after buying an additional 31,565 shares during the last quarter. 93.26% of the stock is owned by institutional investors.

Beauty Health Price Performance

SKIN opened at $0.84 on Monday. The stock’s 50 day simple moving average is $0.72 and its 200 day simple moving average is $0.99. The company has a debt-to-equity ratio of 4.37, a current ratio of 1.79 and a quick ratio of 1.48. Beauty Health has a 1 year low of $0.55 and a 1 year high of $2.69. The firm has a market cap of $109.36 million, a price-to-earnings ratio of -4.96 and a beta of 1.08.

Beauty Health (NASDAQ:SKIN) last announced its quarterly earnings results on Thursday, May 7th. The company reported ($0.05) EPS for the quarter, topping analysts’ consensus estimates of ($0.09) by $0.04. Beauty Health had a negative return on equity of 9.38% and a negative net margin of 2.03%.The business had revenue of $64.91 million for the quarter, compared to analysts’ expectations of $66.28 million. As a group, analysts predict that Beauty Health will post -0.16 earnings per share for the current year.

Beauty Health Company Profile

Beauty Health Company (NASDAQ: SKIN) is a U.S.-based consumer wellness and beauty enterprise that integrates device-based and product-based offerings across skin, body and hair wellness categories. The company operates a portfolio of established brands that blend professional and at-home solutions, focusing on innovative formulations and technologies to address a range of beauty and self-care needs. Through its proprietary e-commerce platforms and strategic retail partnerships, Beauty Health seeks to deliver premium experiences and tangible results to a global customer base.

Beauty Health’s brand portfolio includes Sol de Janeiro, known for its award-winning Brazilian Bum Bum Cream body care collection; Elemis, a U.K.-originated professional skin care line distributed in spas and skincare clinics; NuFACE and Dermaflash, two at-home beauty device brands specializing in microcurrent facial toning and gentle exfoliation respectively; and Nutrafol, a legal-strength hair wellness supplement clinically designed to support hair growth.